Morgan Stanley (NYSE:MS) insider Daniel A. Simkowitz sold 87,050 shares of Morgan Stanley stock in a transaction that occurred on Wednesday, February 14th. The shares were sold at an average price of $53.55, for a total transaction of $4,661,527.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Morgan Stanley (NYSE:MS) opened at $55.14 on Friday. The firm has a market cap of $99,690.00, a price-to-earnings ratio of 17.84, a P/E/G ratio of 0.95 and a beta of 1.54. Morgan Stanley has a fifty-two week low of $40.06 and a fifty-two week high of $58.05. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 2.68.
Morgan Stanley (NYSE:MS) last issued its earnings results on Thursday, January 18th. The financial services provider reported $0.84 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.77 by $0.07. Morgan Stanley had a net margin of 14.10% and a return on equity of 10.03%. The business had revenue of $9.50 billion for the quarter, compared to the consensus estimate of $9.25 billion. During the same period in the previous year, the company earned $0.81 earnings per share. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. analysts anticipate that Morgan Stanley will post 4.51 EPS for the current year.
MS has been the topic of a number of recent research reports. Keefe, Bruyette & Woods reiterated a “buy” rating and issued a $63.00 price objective on shares of Morgan Stanley in a report on Friday, December 22nd. Societe Generale downgraded shares of Morgan Stanley from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Royal Bank of Canada reiterated a “buy” rating and issued a $60.00 price objective on shares of Morgan Stanley in a report on Friday, January 19th. Zacks Investment Research downgraded shares of Morgan Stanley from a “buy” rating to a “hold” rating in a report on Friday, December 29th. Finally, Wells Fargo & Co set a $55.00 price objective on shares of Morgan Stanley and gave the company a “hold” rating in a report on Wednesday, December 20th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $54.07.
Large investors have recently added to or reduced their stakes in the business. Exane Derivatives increased its holdings in shares of Morgan Stanley by 303.9% in the fourth quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock valued at $104,000 after purchasing an additional 1,489 shares during the last quarter. First Dallas Securities Inc. acquired a new position in shares of Morgan Stanley in the fourth quarter valued at $121,000. Invictus RG boosted its position in shares of Morgan Stanley by 307.5% in the third quarter. Invictus RG now owns 2,335 shares of the financial services provider’s stock valued at $112,000 after acquiring an additional 1,762 shares during the period. Rational Advisors LLC bought a new stake in shares of Morgan Stanley in the third quarter valued at about $116,000. Finally, Zions Bancorporation boosted its position in shares of Morgan Stanley by 176.1% in the third quarter. Zions Bancorporation now owns 2,463 shares of the financial services provider’s stock valued at $119,000 after acquiring an additional 1,571 shares during the period. Hedge funds and other institutional investors own 86.55% of the company’s stock.
About Morgan Stanley
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.